アポトーシスアッセイ市場規模、シェア、動向分析レポート：製品別、手法別、アッセイタイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

アポトーシスアッセイ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のアポトーシスアッセイ市場規模は2030年までに105億7,000万米ドルに達し、CAGR 8.65％で拡大すると予測されています。

薬剤誘発アポトーシスアッセイの用途拡大に関する広範な調査活動が、創薬や薬剤設計プロセスにおける細胞周期製品の組み込みに対する製薬メーカーの傾斜を後押ししています。

複雑な実験にも対応できる手頃な価格で実行しやすいキットの導入は、アポトーシス実験にかかる諸経費を最小限に抑えることが期待されます。各社は高精度の試薬とサンプル測定におけるロット間の再現性を提供しています。

製薬会社の専門家は、細胞周期阻害剤やアポトーシス誘導因子（AIF）/分子を利用して、可能性のある創薬標的を探索しています。また、アポトーシス検出のために、製薬会社全体でBcl-2タンパク質ファミリーとともにカスパーゼ活性アッセイに対する高い需要が近年観察されています。バイオテクノロジー企業は、アポトーシス細胞動態のリアルタイムモニタリングを可能にする定量化技術を強化しています。

確立されたガイドラインと細胞賦活アッセイ用プロトコルの存在が、効率的な細胞死検出アッセイの開発を強化しています。一方、細胞力測定法の承認に関する厳しい規制が、発売された製品の市場浸透を確実なものにしています。

フローサイトメトリーセグメントが市場を独占し、2019年に最大の収益シェアを占めました。これは、研究者の間でこの技術の採用が増加していることに起因しています。無傷のミトコンドリア（健康な細胞）と透過したミトコンドリア（死滅しつつある細胞）の違いを見つけるのに役立ちます。このセグメントは予測期間中に急成長すると予測されています。

製薬とバイオテクノロジーセグメントは、2019年に市場を独占し、予測期間中もその支配が続くと予測されています。この背景には、がんや神経変性疾患の罹患率の上昇があります。さらに、慢性疾患の治療におけるプログラム細胞死またはアポトーシスの重要性の高まりが、このセグメントの成長を促進しています。

アポトーシスアッセイ市場レポートハイライト

• キットセグメントが市場を独占し、主要市場参入企業の投資増加により約54.71%の収益シェアを占めました。
• カスパーゼの蛍光標識阻害剤の需要の増加により、試薬が市場で最も急成長している製品セグメントとなっています。
• これらの阻害剤を他の技術に応用することで、アポトーシス評価が強化され、それによってこのセグメントの成長が促進されると予想されます。
• 新薬の発見や先進治療の開発において、プログラムされた細胞死を継続的にモニタリングすることの重要性が高まっていることが、市場の成長を後押ししています。
• 北米は2024年の売上シェアで市場を独占しており、アジア太平洋は同地域のCRO情勢が拡大していることから、今後数年間で最も速い成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 アポトーシスアッセイ市場の変数と動向

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• アポトーシスアッセイ市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 アポトーシスアッセイ市場：製品別、推定・動向分析

• 製品セグメントダッシュボード
• 世界のアポトーシスアッセイ市場の製品変動分析
• 世界のアポトーシスアッセイ市場規模と動向分析（製品別、2018～2030年）
• キット
  • キット市場の規模と予測と動向分析、2018～2030年
• 試薬
  • 試薬市場規模と予測と動向分析、2018～2030年
• 機器
  • 機器市場の規模と予測と動向分析、2018～2030年

第5章 アポトーシスアッセイ市場：手法別、推定・動向分析

• テクニックセグメントダッシュボード
• 世界のアポトーシスアッセイ市場の手法変動分析
• 世界のアポトーシスアッセイ市場規模と動向分析（手法別、2018～2030年）
• フローサイトメトリー
  • フローサイトメトリー市場規模・予測・動向分析（2018～2030年）
• 蛍光顕微鏡
  • 蛍光顕微鏡市場規模・予測・動向分析（2018～2030年）
• 分光光度計
  • 分光光度計市場規模と予測と動向分析、2018～2030年
• その他
  • その他の技術市場規模と予測と動向分析、2018～2030年

第6章 アポトーシスアッセイ市場：アッセイタイプ別、推定・動向分析

• アッセイタイプセグメントダッシュボード
• 世界のアポトーシスアッセイ市場のアッセイタイプ変動分析
• 世界のアポトーシスアッセイ市場規模と動向分析（アッセイタイプ別、2018～2030年）
• カスパーゼアッセイ
  • カスパーゼアッセイ市場規模と予測と動向分析、2018～2030年
• DNAセグメント化アッセイ
  • DNAセグメント化アッセイ市場規模と予測と動向分析、2018～2030年
• 細胞透過性アッセイ
  • 細胞透過性アッセイ市場規模と予測と動向分析、2018～2030年
• ミトコンドリアアッセイ
  • ミトコンドリアアッセイ市場規模・予測・動向分析（2018～2030年）

第7章 アポトーシスアッセイ市場：最終用途別、推定・動向分析

• 最終用途セグメントダッシュボード
• 世界のアポトーシスアッセイ市場の最終用途変動分析
• 世界のアポトーシスアッセイ市場規模と動向分析（最終用途別、2018～2030年）
• 製薬・バイオテクノロジー企業
  • 製薬・バイオテクノロジー企業市場規模・予測・動向分析（2018～2030年）
• 病院と診断ラボ
  • 病院・診断ラボ市場規模・予測・動向分析（2018～2030年）
• 学術研究機関
  • 学術研究機関市場規模と予測と動向分析、2018～2030年

第8章 アポトーシスアッセイ市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 参入企業
• 企業市況分析、2024年
• 戦略マッピング
• 市場参入企業の概要
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories
  • Bio-Techne
  • Biotium
  • GeneCopoeia, Inc.
  • Becton, Dickinson & Company (BD)
  • Promega Corporation
  • Sartorius AG
  • Merck KGaA
  • Abcam plc.
  • Takara Bio Inc.

List of Tables

• Table 1 List of abbreviations
• Table 2 North America Apoptosis Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 3 North America Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 4 North America Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 5 North America Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 6 North America Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 7 U.S. Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 8 U.S. Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 9 U.S. Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 10 U.S. Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 11 Canada Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 12 Canada Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 13 Canada Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 14 Canada Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 15 Mexico Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 16 Mexico Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 17 Mexico Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 18 Mexico Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 19 Europe Apoptosis Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 20 Europe Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 21 Europe Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 22 Europe Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 23 Europe Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 24 UK Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 25 UK Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 26 UK Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 27 UK Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 28 Germany Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 29 Germany Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 30 Germany Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 31 Germany Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 32 Italy Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 33 Italy Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 34 Italy Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 35 Italy Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 36 France Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 37 France Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 38 France Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 39 France Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 40 Spain Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 41 Spain Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 42 Spain Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 43 Spain Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 44 Sweden Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 45 Sweden Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 46 Sweden Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 47 Sweden Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 48 Denmark Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 49 Denmark Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 50 Denmark Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 51 Denmark Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 52 Norway Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 53 Norway Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 54 Norway Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 55 Norway Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific Apoptosis Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 61 China Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 62 China Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 63 China Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 64 China Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 65 Japan Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 66 Japan Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 67 Japan Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 68 Japan Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 69 India Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 70 India Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 71 India Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 72 India Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 73 South Korea Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 74 South Korea Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 75 South Korea Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 76 South Korea Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 77 Australia Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 78 Australia Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 79 Australia Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 80 Australia Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 81 Thailand Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 82 Thailand Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 83 Thailand Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 84 Thailand Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 85 Latin America Apoptosis Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 86 Latin America Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 87 Latin America Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 88 Latin America Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 89 Latin America Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 90 Brazil Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 91 Brazil Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 92 Brazil Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 93 Brazil Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 94 Argentina Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 95 Argentina Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 96 Argentina Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 97 Argentina Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 98 Middle East Africa Apoptosis Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 99 Middle East Africa Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 100 Middle East Africa Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 101 Middle East Africa Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 102 Middle East Africa Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 103 South Africa Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 104 South Africa Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 105 South Africa Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 106 South Africa Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 111 UAE Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 112 UAE Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 113 UAE Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 114 UAE Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)
• Table 115 Kuwait Apoptosis Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 116 Kuwait Apoptosis Assay Market, by Technique, 2018 - 2030 (USD Million)
• Table 117 Kuwait Apoptosis Assay Market, by Assay Type, 2018 - 2030 (USD Million)
• Table 118 Kuwait Apoptosis Assay Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value-Chain-Based Sizing & Forecasting
• Fig. 6 QFD Modeling for Market Share Assessment
• Fig. 7 Market formulation & Validation
• Fig. 8 Apoptosis Assay Market: Market Outlook
• Fig. 9 Parent Market Outlook
• Fig. 10 Related/Ancillary Market Outlook
• Fig. 11 Penetration and Growth Prospect Mapping
• Fig. 12 Industry Value Chain Analysis
• Fig. 13 Apoptosis Assay Market Driver Impact
• Fig. 14 Apoptosis Assay Market Restraint Impact
• Fig. 15 Apoptosis Assay Market Strategic Initiatives Analysis
• Fig. 16 Apoptosis Assay Market: Product Movement Analysis
• Fig. 17 Apoptosis Assay Market: Product Outlook and Key Takeaways
• Fig. 18 Kits Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 19 Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 20 Instruments Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 21 Apoptosis Assay Market: Technique Movement Analysis
• Fig. 22 Apoptosis Assay Market: Technique Outlook and Key Takeaways
• Fig. 23 Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Fluorescence Microscopy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Spectrophotometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Other Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Apoptosis Assay Market: Assay Type Movement Analysis
• Fig. 28 Apoptosis Assay Market: Assay Type Outlook and Key Takeaways
• Fig. 29 Caspase Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 30 DNA Fragmentation Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Cell Permeability Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Mitochondrial Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Apoptosis Assay Market: End Use Movement Analysis
• Fig. 34 Apoptosis Assay Market: End Use Outlook and Key Takeaways
• Fig. 35 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Hospital & Diagnostic Laboratories Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Global Apoptosis Assay Market: Regional Movement Analysis
• Fig. 39 Global Apoptosis Assay Market: Regional Outlook and Key Takeaways
• Fig. 40 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 U.S. Country Dynamics
• Fig. 42 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Canada Country Dynamics
• Fig. 44 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Mexico Country Dynamics
• Fig. 46 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 UK Country Dynamics
• Fig. 49 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Germany Country Dynamics
• Fig. 51 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 France Country Dynamics
• Fig. 53 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Italy Country Dynamics
• Fig. 55 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Spain Country Dynamics
• Fig. 57 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Denmark Country Dynamics
• Fig. 59 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Sweden Country Dynamics
• Fig. 61 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Norway Country Dynamics
• Fig. 63 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 China Country Dynamics
• Fig. 66 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Japan Country Dynamics
• Fig. 68 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 69 India Country Dynamics
• Fig. 70 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Thailand Country Dynamics
• Fig. 72 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 73 South Korea Country Dynamics
• Fig. 74 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Australia Country Dynamics
• Fig. 76 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Brazil Country Dynamics
• Fig. 79 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Argentina Country Dynamics
• Fig. 81 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 83 South Africa Country Dynamics
• Fig. 84 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Saudi Arabia Country Dynamics
• Fig. 86 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 87 UAE Country Dynamics
• Fig. 88 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Kuwait Country Dynamics
• Fig. 90 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Market Position of Key Market Players

Apoptosis Assay Market Growth & Trends:

The global apoptosis assay market size is expected to reach USD 10.57 billion by 2030, expanding at a CAGR of 8.65%, according to a new report by Grand View Research, Inc. Extensive research activities on expanding applications of drug-induced apoptosis assays have propelled the inclination of pharmaceutical manufacturers towards incorporating cell cycle products in the drug discovery and designing process.

The introduction of affordable and easy to perform kits that can be accommodated in complex experiments is expected to minimize the overhead costs of apoptosis experiments. Companies are providing highly precise reagents and lot-to-lot reproducibility in sample measurements.

Professionals at pharmaceutical companies are making use of cell-cycle inhibitors and Apoptosis-Inducing Factors (AIF)/ molecules to explore possible drug targets. Also, high demand for caspase activity assays along with Bcl-2 protein family across pharmaceutical companies for apoptosis detection has been observed in recent years. Biotechnology companies are enhancing quantification techniques to enable real-time monitoring of apoptotic cellular dynamics.

The presence of established guidelines and protocols for cell-potency assays has strengthened the development of efficient cell-death detection assays. Whereas, stringent regulations with respect to the approval of cell-potency assays are ensuring successful uptake of market products launched.

The flow cytometry segment dominated the market and accounted for the largest revenue share in 2019. This is attributed to the increasing adoption of the technique among researchers. It helps in finding the difference between intact mitochondria (healthy cells) and permeabilized mitochondria (cells undergoing death). The segment is anticipated to grow fast over the forecast period.

The pharmaceutical and biotechnology segment dominated the market in 2019 and is anticipated to continue its dominance over the forecast period. This is attributed to the rising incidence of cancer and neurodegenerative disorders. In addition, the growing significance of programmed cell death or apoptosis to treat chronic diseases is driving the segment growth.

Apoptosis Assay Market Report Highlights:

• The kits segment dominated the market and accounted for a revenue share of around 54.71% owing to increasing investment by key market players
• Increase in the demand for fluorochrome-labeled inhibitors of caspases has made reagents the fastest growing product segment in the market
• Application of these inhibitors with other techniques is anticipated to enhance the apoptosis assessment, thereby driving segment growth
• The increasing significance of continuous monitoring of programmed cell death across novel drug discoveries and development of advanced therapeutics is set to propel market growth
• North America has dominated the market in terms of revenue share in 2024, and Asia Pacific is expected to witness the fastest growth in the coming years as a result of the expanding CRO landscape in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Technique
  • 1.2.3. Assay Type
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Apoptosis Assay Market Variables & Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Prevalence of Cancer and Chronic Diseases
    • 3.2.1.2. Advancements in Molecular Biology and Drug Discovery
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Cost of Advanced Assay Techniques
    • 3.2.2.2. Lack of Skilled Professionals
• 3.3. Apoptosis Assay Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Apoptosis Assay Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Apoptosis Assay Market Product Movement Analysis
• 4.3. Global Apoptosis Assay Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Kits
  • 4.4.1. Kits Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Reagents
  • 4.5.1. Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.6. Instruments
  • 4.6.1. Instruments Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Apoptosis Assay Market: Technique Estimates & Trend Analysis

• 5.1. Technique Segment Dashboard
• 5.2. Global Apoptosis Assay Market Technique Movement Analysis
• 5.3. Global Apoptosis Assay Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
• 5.4. Flow Cytometry
  • 5.4.1. Flow Cytometry Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.5. Fluorescence Microscopy
  • 5.5.1. Fluorescence Microscopy Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.6. Spectrophotometry
  • 5.6.1. Spectrophotometry Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.7. Other Techniques
  • 5.7.1. Other Techniques Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Apoptosis Assay Market: Assay Type Estimates & Trend Analysis

• 6.1. Assay Type Segment Dashboard
• 6.2. Global Apoptosis Assay Market Assay Type Movement Analysis
• 6.3. Global Apoptosis Assay Market Size & Trend Analysis, by Assay Type, 2018 to 2030 (USD Million)
• 6.4. Caspase Assays
  • 6.4.1. Caspase Assays Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
• 6.5. DNA Fragmentation Assays
  • 6.5.1. DNA Fragmentation Assays Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
• 6.6. Cell Permeability Assays
  • 6.6.1. Cell Permeability Assays Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
• 6.7. Mitochondrial Assays
  • 6.7.1. Mitochondrial Assays Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)

Chapter 7. Apoptosis Assay Market: End Use Estimates & Trend Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Apoptosis Assay Market End Use Movement Analysis
• 7.3. Global Apoptosis Assay Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.5. Hospital & Diagnostic Laboratories
  • 7.5.1. Hospital & Diagnostic Laboratories Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 8. Apoptosis Assay Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Company Market Position Analysis, 2024
• 9.3. Strategy Mapping
• 9.4. Participants Overview
  • 9.4.1. Thermo Fisher Scientific, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Bio-Rad Laboratories
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Bio-Techne
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Biotium
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. GeneCopoeia, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Becton, Dickinson & Company (BD)
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Promega Corporation
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Sartorius AG
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Merck KGaA
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Abcam plc.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Takara Bio Inc.
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives